Kenneth E. Palmer
Impact in
- Biotechnology top 0.2%
- Transgenic Plants and Applications
- Virology top 1%
- HIV Research and Treatment
Papers in
-
- Plant tissue culture and regeneration 10
-
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 8
- Co-authors
- Edward P. Rybicki (11 shared papers)Alison A. McCormick (8 shared papers)Barry R. O’Keefe (8 shared papers)James B. McMahon (6 shared papers)Gregory P. Pogue (9 shared papers)Amanda B. Lasnik (13 shared papers)J. Calvin Kouokam (6 shared papers)Mark L. Smith (6 shared papers)
- Journals
- Scientific Reports (6 papers)Antimicrobial Agents and Chemotherapy (5 papers)Virology (4 papers)Vaccine (3 papers)Plant Biotechnology Journal (3 papers)
- Partner nations
- United StatesSouth AfricaBelgium
In The Last Decade
Kenneth E. Palmer
83 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 111
- Biotechnology 969
- Virology 459
- Infectious Diseases 787
- Microbiology 254
- Molecular Biology 1.5k
Countries citing papers authored by Kenneth E. Palmer
This map shows the geographic impact of Kenneth E. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth E. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth E. Palmer more than expected).
Fields of papers citing papers by Kenneth E. Palmer
This network shows the impact of papers produced by Kenneth E. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth E. Palmer. The network helps show where Kenneth E. Palmer may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenneth E. Palmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 243 | |
| 2 | 2009 | 208 | |
| 3 | 2020 | 140 | |
| 4 | 2006 | 139 | |
| 5 | 2010 | 135 | |
| 6 | 2006 | 133 | |
| 7 | 2011 | 127 | |
| 8 | 2016 | 113 | |
| 9 | 2007 | 101 | |
| 10 | 2011 | 99 | |
| 11 | 2013 | 96 | |
| 12 | 2013 | 88 | |
| 13 | 1998 | 85 | |
| 14 | 2019 | 81 | |
| 15 | 2002 | 74 | |
| 16 | 2006 | 65 | |
| 17 | 2008 | 61 | |
| 18 | 2006 | 59 | |
| 19 | 2007 | 52 | |
| 20 | 2006 | 51 |
About Kenneth E. Palmer
Kenneth E. Palmer is a scholar working on Molecular Biology, Infectious Diseases, Biotechnology, Epidemiology and Plant Science, having authored 84 papers that have together received 3.3k indexed citations. Recurring topics across this work include Transgenic Plants and Applications (23 papers), Plant Virus Research Studies (21 papers), HIV Research and Treatment (16 papers), Herpesvirus Infections and Treatments (12 papers), Plant tissue culture and regeneration (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and COVID-19 Clinical Research Studies (8 papers). The work is most often cited by research in Biotechnology (969 citations), Virology (459 citations), Infectious Diseases (787 citations), Microbiology (254 citations) and Molecular Biology (1.5k citations). Kenneth E. Palmer has collaborated with scholars based in United States, South Africa and Belgium. Frequent co-authors include Edward P. Rybicki, Alison A. McCormick, Barry R. O’Keefe, James B. McMahon, Gregory P. Pogue, Amanda B. Lasnik, J. Calvin Kouokam, Mark L. Smith, Fakhrieh Vojdani and Nobuyuki Matoba. Their work appears in journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy, Virology, Vaccine and Plant Biotechnology Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.